139 related articles for article (PubMed ID: 28027004)
1. Has VZV epidemiology changed in Italy? Results of a seroprevalence study.
De Donno A; Kuhdari P; Guido M; Rota MC; Bella A; Brignole G; Lupi S; Idolo A; Stefanati A; Del Manso M; Gabutti G;
Hum Vaccin Immunother; 2017 Feb; 13(2):385-390. PubMed ID: 28027004
[TBL] [Abstract][Full Text] [Related]
2. Varicella zoster virus infection occurs at a relatively young age in The Netherlands.
van Lier A; Smits G; Mollema L; Waaijenborg S; Berbers G; van der Klis F; Boot H; Wallinga J; de Melker H
Vaccine; 2013 Oct; 31(44):5127-33. PubMed ID: 23973248
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of varicella-zoster virus in the German population.
Wutzler P; Färber I; Wagenpfeil S; Bisanz H; Tischer A
Vaccine; 2001 Oct; 20(1-2):121-4. PubMed ID: 11567755
[TBL] [Abstract][Full Text] [Related]
4. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of varicella-zoster virus in Polish population.
Siennicka J; Trzcińska A; Rosińska M; Litwińska B
Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
[TBL] [Abstract][Full Text] [Related]
6. [Sero-epidemiology of VZV infection in Italy: impact evaluation of extensive vaccination].
Gabutti G; Rota MC; De Donno A; Guido M; Bella A; Idolo A; Lupi S; Brignole G;
Epidemiol Prev; 2014; 38(6 Suppl 2):57-61. PubMed ID: 25759345
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
[TBL] [Abstract][Full Text] [Related]
8. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy.
Kudesia G; Partridge S; Farrington CP; Soltanpoor N
J Clin Pathol; 2002 Feb; 55(2):154-5. PubMed ID: 11865016
[TBL] [Abstract][Full Text] [Related]
9. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
[TBL] [Abstract][Full Text] [Related]
10. Antibody induced by one-dose varicella vaccine soon became weak in children: evidence from a cross-sectional seroepidemiological survey in Beijing, PRC.
Suo L; Lu L; Chen M; Pang X
BMC Infect Dis; 2015 Nov; 15():509. PubMed ID: 26554449
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial transmission of chickenpox and varicella zoster virus seroprevalence rate amongst healthcare workers in a teaching hospital in China.
Yang J; Liu J; Xing F; Ye H; Dai G; Liu M; Lo SK; Lau RW; Chiu KH; Chan JF; Yuen KY
BMC Infect Dis; 2019 Jul; 19(1):582. PubMed ID: 31277589
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence survey for Varicella among healthcare workers and medical students in Italy.
Balbi O; Baldi S; Rizza S; Pietroiusti A; Perrone S; Coppeta L
Hum Vaccin Immunother; 2021 Feb; 17(2):372-376. PubMed ID: 32643520
[TBL] [Abstract][Full Text] [Related]
13. The seroepidemiology of varicella in Italy.
Gabutti G; Penna C; Rossi M; Salmaso S; Rota MC; Bella A; Crovari P;
Epidemiol Infect; 2001 Jun; 126(3):433-40. PubMed ID: 11467800
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of Varicella Zoster Virus infection in Italy.
Gabutti G; Rota MC; Guido M; De Donno A; Bella A; Ciofi degli Atti ML; Crovari P;
BMC Public Health; 2008 Oct; 8():372. PubMed ID: 18954432
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of varicella zoster antibodies among children with malnutrition, malignancies and HIV infection.
Admani B; Macharia WM; Were F
East Afr Med J; 2008 Oct; 85(10):480-6. PubMed ID: 19537424
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.
van Rijckevorsel GG; Damen M; Sonder GJ; van der Loeff MF; van den Hoek A
BMC Infect Dis; 2012 Jun; 12():140. PubMed ID: 22721551
[TBL] [Abstract][Full Text] [Related]
17. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.
Semenovitch I; Lupi O
Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
Alfonsi V; Montomoli E; Manini I; Alberini I; Gentile C; Rota MC; Ciofi degli Atti ML
Vaccine; 2007 Aug; 25(32):6086-8. PubMed ID: 17629374
[TBL] [Abstract][Full Text] [Related]
19. Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college students.
Mahamud A; Leung J; Masunu-Faleafaga Y; Teshale E; Williams R; Dulski T; Thieme M; Garcia P; Schmid DS; Bialek SR
Epidemiol Infect; 2014 May; 142(5):1002-7. PubMed ID: 23890292
[TBL] [Abstract][Full Text] [Related]
20. THE changing seroepidemiology of varicella in Japan: 1977-1981 and 2001-2005.
Ueno-Yamamoto K; Tanaka-Taya K; Satoh H; Araki K; Kaku M; Okabe N
Pediatr Infect Dis J; 2010 Jul; 29(7):667-9. PubMed ID: 20228693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
